These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7739004)

  • 1. Synthesis and in vitro evaluation of 4-substituted N-(1,1-dimethylethyl)-3-oxo-4-androstene-17 beta-carboxamides as 5 alpha-reductase inhibitors and antiandrogens.
    Li X; Singh SM; Côté J; Laplante S; Veilleux R; Labrie F
    J Med Chem; 1995 Apr; 38(9):1456-61. PubMed ID: 7739004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro activity of 17 beta-(N-alkyl/arylformamido)- and 17 beta-[(N-alkyl/aryl)alkyl/arylamido]-4-methyl-4-aza-3-oxo-5 alpha-androstan-3-ones as inhibitors of human 5 alpha-reductases and antagonists of the androgen receptor.
    Li X; Singh SM; Labrie F
    J Med Chem; 1995 Mar; 38(7):1158-73. PubMed ID: 7707319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Methyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-N-aryl-carboxamides: an approach to combined androgen blockade [5alpha-reductase inhibition with androgen receptor binding in vitro].
    Tolman RL; Sahoo SP; Bakshi RK; Gratale D; Patel G; Patel S; Toney J; Chang B; Harris GS
    J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):303-9. PubMed ID: 9219921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinyl fluoride as a mimic of the "intermediate' enol form in the 5 alpha-reductase transformation: synthesis and in vitro activity of (N-1',1'-dimethylethyl)-3-haloandrost-3,5-diene-17 beta-carboxamides.
    Li X; Singh SM; Luu-The V; Côté J; Laplante S; Labrie F
    Bioorg Med Chem; 1996 Jan; 4(1):55-60. PubMed ID: 8689240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroidal antiandrogens and 5alpha-reductase inhibitors.
    Bratoeff E; Ramírez E; Murillo E; Flores G; Cabeza M
    Curr Med Chem; 1999 Dec; 6(12):1107-23. PubMed ID: 10519917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
    Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
    J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
    Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
    Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the chemistry and pharmacological activity of new steroidal antiandrogens and 5 alpha-reductase inhibitors.
    Bratoeff E; Cabeza M; Ramirez E; Heuze Y; Flores E
    Curr Med Chem; 2005; 12(8):927-43. PubMed ID: 15853706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5 Alpha-reductase inhibitory and antiandrogenic activities of novel steroids in hamster seminal vesicles.
    Cabeza M; Bratoeff E; Flores E; Ramírez E; Calleros J; Montes D; Quiroz A; Heuze I
    Chem Pharm Bull (Tokyo); 2002 Nov; 50(11):1447-52. PubMed ID: 12419908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of antiandrogens on growth of androgen-dependent mouse mammary tumor (Shionogi carcinoma 115) in vivo and in vitro.
    Suzuki T; Horibe I; Uchida N; Ezumi K; Uchida K; Takeda K; Tanaka A; Nishizawa Y; Matsumoto K
    J Steroid Biochem Mol Biol; 1990 Nov; 37(4):559-67. PubMed ID: 2278840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New aromatic esters of progesterone as antiandrogens.
    Bratoeff E; Ramírez E; Flores E; Sánchez M; Heuze I; Cabeza M
    J Enzyme Inhib Med Chem; 2004 Apr; 19(2):99-105. PubMed ID: 15449723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro study of rat prostate 5 alpha-reductase activity and its inhibition.
    Faredin I; Tóth I; Oszlánczy J; Scultéty S
    Int Urol Nephrol; 1992; 24(2):145-54. PubMed ID: 1624258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-Aza-3-oxo-5 alpha-androst-1-ene-17 beta-N-aryl-carboxamides as dual inhibitors of human type 1 and type 2 steroid 5 alpha-reductases. Dramatic effect of N-aryl substituents on type 1 and type 2 5 alpha-reductase inhibitory potency.
    Bakshi RK; Rasmusson GH; Patel GF; Mosley RT; Chang B; Ellsworth K; Harris GS; Tolman RL
    J Med Chem; 1995 Aug; 38(17):3189-92. PubMed ID: 7650670
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and pharmacological evaluation of 4-halo progesterone derivatives as antiandrogen.
    Cabeza M; Quiroz A; Bratoeff E; Murillo ME; Ramírez E; Flores G
    Chem Pharm Bull (Tokyo); 1999 Sep; 47(9):1232-6. PubMed ID: 10517005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel non-steroidal/non-anilide type androgen antagonists with an isoxazolone moiety.
    Ishioka T; Kubo A; Koiso Y; Nagasawa K; Itai A; Hashimoto Y
    Bioorg Med Chem; 2002 May; 10(5):1555-66. PubMed ID: 11886817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals.
    Körner W; Vinggaard AM; Térouanne B; Ma R; Wieloch C; Schlumpf M; Sultan C; Soto AM
    Environ Health Perspect; 2004 May; 112(6):695-702. PubMed ID: 15121513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mediation by the androgen receptor of the stimulatory and antiandrogenic actions of 17 beta-estradiol on the growth of androgen-sensitive Shionogi mammary carcinoma cells in culture.
    Luthy IA; Bégin D; Labrie F
    Endocrinology; 1988 Sep; 123(3):1418-24. PubMed ID: 3402389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive in vitro test systems to determine androgenic/antiandrogenic activity.
    Guth SE; Böhm S; Mussler BH; Eisenbrand G
    Mol Nutr Food Res; 2004 Sep; 48(4):282-91. PubMed ID: 15497179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel non-steroidal/non-anilide type androgen antagonists: discovery of 4-substituted pyrrole-2-carboxamides as a new scaffold for androgen receptor ligands.
    Wakabayashi K; Miyachi H; Hashimoto Y; Tanatani A
    Bioorg Med Chem; 2005 Apr; 13(8):2837-46. PubMed ID: 15781394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.